These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 298337)

  • 61. The effects of neuroleptics with central dopamine and noradrenaline receptor blocking properties in the L-DOPA and (+)-amphetamine-induced waking EEG in the rat.
    Monti JM
    Br J Pharmacol; 1979 Sep; 67(1):87-91. PubMed ID: 40644
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of d-amphetamine on tryptophan and other aromatic amino acids in brain.
    Fernando JC; Curzon G
    Eur J Pharmacol; 1978 Jun; 49(4):339-49. PubMed ID: 149670
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effects of dopamine agonists on human cardiovascular and sympathetic nervous systems.
    Ziegler MG; Kennedy B; Holland OB; Murphy D; Lake CR
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):175-9. PubMed ID: 3158615
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CSF dopamine beta-hydroxylase in schizophrenia.
    Sternberg DE; van Kammen DP; Lerner P; Ballenger JC; Marder SR; Post RM; Bunney WE
    Arch Gen Psychiatry; 1983 Jul; 40(7):743-7. PubMed ID: 6134515
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Raised cerebrospinal fluid norepinephrine in some patients with primary hypertension.
    Eide I; Kolloch R; De Quattro V; Miano L; Dugger R; Van der Meulen J
    Hypertension; 1979; 1(3):255-60. PubMed ID: 399237
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Deficient sympathetic nervous response in familial dysautonomia.
    Ziegler MG; Lake CR; Kopin IJ
    N Engl J Med; 1976 Mar; 294(12):630-3. PubMed ID: 1246255
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dextro-amphetamine diminishes negative symptoms in schizophrenia.
    van Kammen DP; Boronow JJ
    Int Clin Psychopharmacol; 1988 Apr; 3(2):111-21. PubMed ID: 3294284
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Plasma norepinephrine and dopamine-beta-hydroxylase in dystonia.
    Ziegler MG; Lake CR; Eldridge R; Kopin IJ
    Adv Neurol; 1976; 14():307-18. PubMed ID: 941776
    [No Abstract]   [Full Text] [Related]  

  • 69. A parametric evaluation of the hedonic and motoric effects of drugs: pimozide and amphetamine.
    Heyman GM
    J Exp Anal Behav; 1983 Sep; 40(2):113-22. PubMed ID: 6631310
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dopamine-beta-hydroxylase and its apparent endogenous inhibitory activity in the plasma of some psychiatric patients.
    Yu PH; O'Sullivan KS; Keegan D; Boulton AA
    Psychiatry Res; 1980 Oct; 3(2):205-10. PubMed ID: 6947313
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 24-hour rhythm of human plasma noradrenaline and the effect of fusaric acid, a dopamine-beta-hydroxylase inhibitor.
    Kato T; Hashimoto Y; Nagatsu T; Shinoda T; Okada T; Takeuchi T; Umezawa H
    Neuropsychobiology; 1980; 6(2):61-5. PubMed ID: 7354907
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus.
    Cooper BR; Konkol RJ; Breese GR
    J Pharmacol Exp Ther; 1978 Mar; 204(3):592-605. PubMed ID: 24729
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of clonidine on sympathetic nervous system activity in patients with essential hypertension.
    Chernow B; Lake CR; Zaloga GP; Coleman MD; Ziegler MG
    Int J Clin Pharmacol Res; 1983; 3(1):9-15. PubMed ID: 6679510
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Drug interactions on spontaneous locomotor activity in rats. Neuroleptics and amphetamine-induced hyperactivity.
    Schaefer GJ; Michael RP
    Neuropharmacology; 1984 Aug; 23(8):909-14. PubMed ID: 6148710
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dopamine-beta-hydroxylase in patients with cystic fibrosis.
    Schöni MH; Türler K; Käser H; Kraemer R
    Eur J Pediatr; 1986 Apr; 145(1-2):80-3. PubMed ID: 3732334
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism.
    Lake CR; Ziegler MG; Murphy DL
    Arch Gen Psychiatry; 1977 May; 34(5):553-6. PubMed ID: 558741
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Stimulus effects of d-amphetamine II: DA, NE, and 5-HT mechanisms.
    West WB; Van Groll BJ; Appel JB
    Pharmacol Biochem Behav; 1995 May; 51(1):69-76. PubMed ID: 7617735
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of lithium on behaviour induced by phencyclidine and amphetamine in rats.
    Fessler RG; Sturgeon RD; London SF; Meltzer HY
    Psychopharmacology (Berl); 1982; 78(4):373-6. PubMed ID: 6818601
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differential analgetic actions of amphetamine enantiomers in the mouse: a drug-drug interaction study.
    Tocco DR; Spratto GR; Maickel RP
    Arch Int Pharmacodyn Ther; 1985 Dec; 278(2):261-72. PubMed ID: 2937379
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Elevation of plasma dopamine-beta-hydroxylase activity during insulin-induced hypoglycemia in man.
    Okada F; Yamashita I; Suwa N; Kunita H; Hata S
    Experientia; 1975 Jan; 31(1):70-1. PubMed ID: 1112327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.